15 October 2015 - On the campaign trail, Hillary Clinton is proposing to force pharmaceutical companies to spend more on research. In California, the push is on for a law to contain government spending on drugs. And on the front pages of national newspapers, stories keep appearing about high medicine prices.

In Washington, there’s little sign that Congress is ready to advance any of the initiatives sprouting up to address the cost of medicine.

For more details, go to: http://www.bloomberg.com/news/articles/2015-10-14/drug-price-drumbeat-fails-to-resonate-as-washington-stands-still